Cargando…
Bevacizumab-Induced Hypertension in Glioblastoma Patients and Its Potential as a Modulator of Treatment Response
Glioblastoma invasion is the primary mechanism responsible for its dismal prognosis and is the direct result of interactions between glioblastoma cells and the tumor vasculature. The dysregulated microvasculature in glioblastoma tumors and vessels co-opted from surrounding brain tissue support rapid...
Autores principales: | Scheer, Kaitlin G., Ebert, Lisa M., Samuel, Michael S., Bonder, Claudine S., Gomez, Guillermo A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355799/ https://www.ncbi.nlm.nih.gov/pubmed/37340980 http://dx.doi.org/10.1161/HYPERTENSIONAHA.123.21119 |
Ejemplares similares
-
Spinal Dissemination of Intracranial Glioblastoma in Bevacizumab Era: a Potential Bevacizumab-induced Mechanism
por: Kaloshi, Gentian, et al.
Publicado: (2014) -
Endothelial, pericyte and tumor cell expression in glioblastoma identifies fibroblast activation protein (FAP) as an excellent target for immunotherapy
por: Ebert, Lisa M, et al.
Publicado: (2020) -
Bevacizumab for glioblastoma
por: Narita, Yoshitaka
Publicado: (2015) -
Bevacizumab for the Treatment of Glioblastoma
por: Gil-Gil, Miguel J., et al.
Publicado: (2013) -
Bevacizumab in recurrent glioblastoma
por: Martinez, Nina L., et al.
Publicado: (2019)